Recent Finacing
Recent Raise
Claris Bio is a late‑clinical‑stage biotech developing oremepermin‑α (CSB‑001), a topical recombinant HGF biologic for corneal diseases, conducting a multicenter, randomized, double‑masked trial and pursuing multiple ophthalmic indications.
